Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FRVK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,431
Award facts
- Contract value 100% obligated
- $16,430.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) under a firm fixed-price contract valued at $16,430.68, with an ultimate completion date of September 15, 2025. This non-competitive delivery order was issued on September 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply vehicle running through December 2026 that enables the company to deliver pharmaceuticals and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards through the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Gemtesa, a urological pharmaceutical, exemplifies the company's role in supporting Defense Health Agency medical procurement through competitively awarded, firm fixed-price delivery mechanisms under its prime indefinite delivery contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FRVK4?
SPE2DB25FRVK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FRVK4 worth?
The government has obligated $16,431 on SPE2DB25FRVK4.
Is contract SPE2DB25FRVK4 an order under another contract?
Yes. SPE2DB25FRVK4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVK4 competed?
The extent of competition for SPE2DB25FRVK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award